sabcs 2014 - web.oncoletter.chweb.oncoletter.ch/.../sabcs2014/s1-01.pdf · 2014 dr. di leo:...

12

SABCS 2014

Upload: others

Post on 25-May-2020

2 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 2: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 3: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 4: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 5: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 6: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 7: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 8: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 9: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 10: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 11: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

Page 12: SABCS 2014 - web.oncoletter.chweb.oncoletter.ch/.../SABCS2014/S1-01.pdf · 2014 Dr. Di Leo: Consulting, Consultnig fees from AstraZeneca and Pfizer; Other Financial, Research Support

SABCS 2014

CASE STUDY AstraZeneca Canada Headquarters - · PDF file2 CASE STUDY AstraZeneca Canada Headquarters Background AstraZeneca Canada, a world leader in pharmaceutical research and

APRIL 25, 2016AHS), Melanie Howe (SABCS) Apr. Student Hosts – Bill Tucker (SAHS), Ralph Courtney (AHS), Bob Newburn (SABCS) Mike Pereyo Speaker Maxwell Carroll Student guest Holly

Company’s - AstraZeneca

Best of SABCS Day 2

Post SABCS 2014 Wirkmechanismen [Kompatibilitätsmodus] · 2015. 5. 28. · 19.01.2015 1 SABCS 2014 Rudolf Weide Praxisklinik für Hämatologie und Onkologie Koblenz Wirkmechanismus

AstraZeneca - NSE India

AstraZeneca Pharma

AstraZeneca 2011

Brochure - Astrazeneca México

SABCS 2012 Surgery Highlights

Radiation Therapy Update: SABCS 2005

AstraZeneca Presentation

BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE … · AstraZeneca Pharmaceuticals LP and AstraZeneca LP (collectively “AstraZeneca”) hereby enter into this Corporate Integrity

Journées thématiques AstraZeneca

SABCS 2014 - oncoletter fileSABCS 2014. SABCS 2014. SABCS 2014. SABCS 2014. SAN ANTONIO BREAST CANCER SAN ANTONIO BREAST CANCER ... enis r distribute. ... Zoppol s, ne Elia magalli,

SABCS 2016 - oncoletterweb.oncoletter.ch/files/cto_layout/Kongressdateien... · SABCS 2016. Disclosure of Potential Conflicts of Interest Employment: Immediate Family Member Sandoz

SABCS Congress webinar HR+/HER2- Advanced breast cancer ......• SABCS 2019 –Efficacy and safety –Extended and subgroup analyses ... •Abemaciclib plus fulvestrant led to a median

2005 SABCS Review: Surgery, Radiation, and Prevention

Global Operations - AstraZeneca

Baselga J et al. SABCS 2009;Abstract 45

Best of SABCS 2012 Radiation Oncology

Apprenticeships at AstraZeneca

AstraZeneca Центр Стамбула

KONGRESSBERICHT SABCS 2010: Was ist E für die Praxis ...dokrinen Resistenz. Auf dem SABCS wurden zwei größere Studien mit dieser Fragestellung vorgestellt. In der französischen

Astrazeneca Full year and_q4_2016_results_presentation

Neo-adjuvant Treatment SABCS 2011 - GBECAM · Neo-adjuvant Treatment SABCS 2011 Carlos H. Barrios, MD Instituto do Câncer HMD Faculdade de Medicina PUCRS Porto Alegre, Brazil

Metastatic HR+, TNBC, & Bisphosphonates Abstracts SABCS Rev 01...SABCS 2009 (FACT) 514 Anastrozole (38.2) Anastrozole + Fulvestrant (37.8) 1.00 1.00 Nabholtz 2003 Eur J C 1021 Tamoxifen

AstraZeneca - MSAC

ASTRAZENECA il progetto Telelavoro ASTRAZENECA. 2 AstraZeneca Global & Italia Presente in oltre 100 Paesi (Sede centrale in UK) Oltre 62.000 dipendenti

Neues vom SABCS 2009 - Tumorzentrum München...Neues vom SABCS 2009 Adjuvante Therapie Dr. B. Ataseven Leitende Oberärztin ROTKREUZKLINIKUM München, Frauenklinik Ärztlicher Direktor:

INDEPENDENT RESEARCH AstraZeneca

35 th SABCS 2012 Highlights Loco-Regional Therapy